Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve

Reproductive Sciences

Volumn 19, Issue 11, 2012, Pages 1226-1231

  Pastore, Lisa M ^a   Young, Steven L ^b   Baker, Valerie L ^c   Karns, Logan B ^a   Williams, Christopher D ^d   Silverman, Lawrence M ^e  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c STANFORD UNIVERSITY   (United States)

^d Reproductive Medicine and Surgery Center of Virginia   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

diminished ovarian reserve; epidemiology; female infertility; FMR1; FXPOI; trinucleotide repeats

Indexed keywords

CYSTEINYLGLYCYLGLYCINE; FRAGILE X MENTAL RETARDATION PROTEIN; TRINUCLEOTIDE; UNCLASSIFIED DRUG;

ADULT; AMENORRHEA; ARTICLE; DISEASE ASSOCIATION; FEMALE; FEMALE INFERTILITY; FRAGILE X SYNDROME; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; OVARIAN RESERVE; PHENOTYPE; PREMATURE OVARIAN FAILURE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRINUCLEOTIDE REPEAT;

ADULT; AMENORRHEA; COHORT STUDIES; FEMALE; FOLLICLE STIMULATING HORMONE; FRAGILE X MENTAL RETARDATION PROTEIN; HUMANS; INFERTILITY, FEMALE; INTELLECTUAL DISABILITY; PRIMARY OVARIAN INSUFFICIENCY; PROSPECTIVE STUDIES; TRINUCLEOTIDE REPEATS;

EID: 84867508355     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719112446074     Document Type: Article

References (30)

1. McConkie-Rosell A, Abrams L, Finucane B, et al. Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders. J Genet Couns. 2007 ; 16 (5). 593-606
2. Nelson LM, Bakalov VK. Mechanisms of follicular dysfunction in 46, XX spontaneous premature ovarian failure. Endocrinol Metab Clin North Am. 2003 ; 32 (3). 613-637
3. Speroff L, Fritz MA Clinical Gynecologic Endocrinology and Infertility. 7 ed. Philadelphia: Lippincott Williams & Wilkins; 2005. Philadelphia: Lippincott Williams & Wilkins ; 2005 :
4. Scott RT, Hofmann GE. Prognostic assessment of ovarian reserve. Fertil Steril. 1995 ; 63 (1). 1-11
5. Levi AJ, Raynault MF, Bergh PA, Drews MR, Miller BT, Scott RT. Reproductive outcome in patients with diminished ovarian reserve. Fertil Steril. 2001 ; 76 (4). 666-669
6. Spector E, Kronquist K Fragile X: Technical standards and guidelines. 2005 :
7. Sherman SL. Premature ovarian failure in the fragile X syndrome. Am J Med Genet. 2000 ; 97 (3). 189-194
8. Garcia-Arocena D, Hagerman PJ. Advances in understanding the molecular basis of FXTAS. Hum Mol Genet. 2010 ; 19 (R1). R83 - R89
9. Sherman S, Pletcher BA, Driscoll DA. Fragile X syndrome: diagnostic and carrier testing. Genet Med. 2005 ; 7 (8). 584-587
10. Carrier Screening for Fragile X Syndrome. Obstet Gynecol. 2010 ; 116 (4). 1008-1010
11. Nolin SL, Brown WT, Glicksman A, et al. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet. 2003 ; 72 (2). 454-464
12. Zuniga A, Juan J, Mila M, Guerrero A. Expansion of an intermediate allele of the FMR1 gene in only two generations. Clin Genet. 2005 ; 68 (5). 471-473
13. Fu YH, Kuhl DPA, Pizzuti A, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991 ; 67 (6). 1047-1058
14. Peprah E. Fragile X syndrome: the FMR1 CGG repeat distribution among world populations. Ann Hum Genet. 2012 ; 76 (2). 178-191
15. Streuli I, Fraisse T, Ibecheole V, Moix I, Morris MA, de Ziegler D. Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency. Fertil Steril. 2009 ; 92 (2). 464-470
16. Bretherick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet. 2005 ; 117 (4). 376-382
17. Otsuka S, Sakamoto Y, Siomi H, et al. Fragile X carrier screening and FMR1 allele distribution in the Japanese population. Brain Dev. 2010 ; 32 (2). 110-114
18. Bodega B, Bione S, Dalpra L, et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod. 2006 ; 21 (4). 952-957
19. Taieb J, Olivennes F, Birr AS, et al. Comparison of day 3 FSH serum values as determined by six different immunoassays. Hum Reprod. 2002 ; 17 (4). 926-928
20. Scriver J, Baker V, Young S, Behr B, Pastore L. Inter-laboratory validation of the measurement of follicle stimulating hormone (FSH) after various lengths of frozen storage. Reprod Biol Endocrinol. 2010 ; 8 (1). 145
21. Larsen LA, Grønskov K, Nørgaard-Pedersen B, Brøndum-Nielsen K, Hasholt L, Vuust J. High-throughput analysis of Fragile X (CGG)n alleles in the normal and premutation range by PCR amplification and automated capillary electrophoresis. Hum Genet. 1997 ; 100 (5-6). 564-568
22. Gleicher N, Weghofer A, Oktay K, Barad D. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. Reprod Biomed Online. 2009 ; 19 (3). 385-390
23. Gleicher N, Weghofer A, Barad DH. Effects of race/ethnicity on triple CGG counts in the FMR1 gene in infertile women and egg donors. Reprod Biomed Online. 2010 ; 20 (4). 485-491
24. Gleicher N, Weghofer A, Lee IH, Barad DH. Association of FMR1 genotypes with in vitro fertilization (IVF) outcomes based on ethnicity/race. PLoS One. 2011 ; 6 (4). e18781
25. Maddalena A, Richards CS, McGinniss MJ, et al. Technical standards and guidelines for fragile X: the first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee. Genet Med. 2001 ; 3 (3). 200-205
26. Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertil Steril. 2009 ; 91 (5). 1700-1706
27. Ficicioglu C, Yildirim G, Attar R, Kumbak B, Yesildaglar N. The significance of the number of CGG repeats and autoantibodies in premature ovarian failure. Reprod Biomed Online. 2010 ; 20 (6). 776-782
28. Gleicher N, Weghofer A, Oktay K, Barad DH. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test?. Acta Obstet Gynecol Scand. 2009 ; 88 (9). 1024-1030
29. Gleicher N, Weghofer A, Barad D. Ovarian reserve determinations suggest new finction of FMR1 (fragile X gene) in regulating ovarian ageing. Reprod Biomed Online. 2010 ; 20 (6). 768-775
30. Cronister A, Teicher J, Rohlfs EM, Donnenfeld A, Hallam S. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis. Obstet Gynecol. 2008 ; 111 (3). 596-601